- Yale Cancer Answers
- ASH CME Series
- Smilow Shares with Primary Care
- 2021 ASH Highlights
- Grand Rounds
- Head and Neck
- Gynecologic
- Benign Hematology
- Breast
- GI
- Lung
- GU
- Hematologic Oncology
- Brain
- Cancer Screening
- DEI (Diversity, Equity and Inclusion)
- General Events
Playback speed
10 seconds
Immune Response to COVID-19: What is the Observed WBC and Moncyte Count in Patients With Progressive Disease and Those Who Recover?
By
Yale Cancer Center
FEATURING
Akiko Iwasaki
By
Yale Cancer Center
FEATURING
Akiko Iwasaki
16 views
February 11, 2021
Login to view comments.
Click here to Login
General Oncology